Risk-benefit assessment of nimesulide urgently needed

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2003年 / 934卷 / 1期
关键词：
Public Health; High Risk; Clinical Pharmacology; System Database; Nimesulide;
D O I：
10.2165/00128415-200309340-00005
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [1] Nimesulide risk-benefit profile favourable
    [J]. Reactions Weekly, 2003, 963 (1) : 2 - 2
  • [2] Risk-Benefit Assessment of Foods
    Assuncao, R.
    Pires, S. M.
    Nauta, M.
    [J]. EFSA JOURNAL, 2019, 17
  • [3] A Risk-Benefit Assessment of Amifostine in Cytoprotection
    May Mabro
    Sandrine Faivre
    Eric Raymond
    [J]. Drug Safety, 1999, 21 : 367 - 387
  • [4] A Risk-Benefit Assessment of Antileukotrienes in Asthma
    Lewis J. Smith
    [J]. Drug Safety, 1998, 19 : 205 - 218
  • [5] A RISK-BENEFIT ASSESSMENT OF RISPERIDONE IN SCHIZOPHRENIA
    CURTIS, VA
    KERWIN, RW
    [J]. DRUG SAFETY, 1995, 12 (02) : 139 - 145
  • [6] Risk-benefit ratio or risk-benefit nonsense?
    Ernst, E
    Resch, KL
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (10) : 1203 - 1204
  • [7] A RISK-BENEFIT ASSESSMENT OF TAMOXIFEN THERAPY
    CATHERINO, WH
    JORDAN, VC
    [J]. DRUG SAFETY, 1993, 8 (05) : 381 - 397
  • [8] A risk-benefit assessment of abciximab in angioplasty
    Kleiman, NS
    [J]. DRUG SAFETY, 1999, 20 (01) : 43 - 57
  • [9] A RISK-BENEFIT ASSESSMENT OF TACROLIMUS IN TRANSPLANTATION
    WINKLER, M
    CHRISTIANS, U
    [J]. DRUG SAFETY, 1995, 12 (05) : 348 - 357
  • [10] THE RISK-BENEFIT ASSESSMENT OF ANTIDEPRESSANT DRUGS
    HENRY, JA
    MARTIN, AJ
    [J]. MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1987, 2 (06): : 445 - 462
12345